SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-23-063212
Filing Date
2023-05-22
Accepted
2023-05-22 17:00:26
Documents
39

Document Format Files

Seq Description Document Type Size
1 SC TO-C tm2316414d1_sctoc.htm SC TO-C 24651
2 EXHIBIT 99.1 tm2316414d1_ex99-1.htm EX-99.1 44900
3 EXHIBIT 99.2 tm2316414d1_ex99-2.htm EX-99.2 24692
4 EXHIBIT 99.3 tm2316414d1_ex99-3.htm EX-99.3 43684
5 EXHIBIT 99.4 tm2316414d1_ex99-4.htm EX-99.4 48565
6 EXHIBIT 99.5 tm2316414d1_ex99-5.htm EX-99.5 48359
7 EXHIBIT 99.6 tm2316414d1_ex99-6.htm EX-99.6 12102
8 EXHIBIT 99.7 tm2316414d1_ex99-7.htm EX-99.7 8115
9 GRAPHIC tm2316414d1_ex99-1img001.jpg GRAPHIC 7692
10 GRAPHIC tm2316414d1_ex99-2img001.jpg GRAPHIC 758309
11 GRAPHIC tm2316414d1_ex99-2img002.jpg GRAPHIC 979392
12 GRAPHIC tm2316414d1_ex99-2img003.jpg GRAPHIC 341937
13 GRAPHIC tm2316414d1_ex99-2img004.jpg GRAPHIC 573151
14 GRAPHIC tm2316414d1_ex99-2img005.jpg GRAPHIC 416996
15 GRAPHIC tm2316414d1_ex99-2img006.jpg GRAPHIC 712048
16 GRAPHIC tm2316414d1_ex99-2img007.jpg GRAPHIC 432510
17 GRAPHIC tm2316414d1_ex99-2img008.jpg GRAPHIC 499205
18 GRAPHIC tm2316414d1_ex99-2img009.jpg GRAPHIC 368432
19 GRAPHIC tm2316414d1_ex99-2img010.jpg GRAPHIC 353972
20 GRAPHIC tm2316414d1_ex99-2img011.jpg GRAPHIC 366293
21 GRAPHIC tm2316414d1_ex99-2img012.jpg GRAPHIC 698295
22 GRAPHIC tm2316414d1_ex99-2img013.jpg GRAPHIC 242170
23 GRAPHIC tm2316414d1_ex99-2img014.jpg GRAPHIC 378265
24 GRAPHIC tm2316414d1_ex99-2img015.jpg GRAPHIC 426625
25 GRAPHIC tm2316414d1_ex99-2img016.jpg GRAPHIC 391114
26 GRAPHIC tm2316414d1_ex99-2img017.jpg GRAPHIC 269318
27 GRAPHIC tm2316414d1_ex99-4img001.jpg GRAPHIC 10439
28 GRAPHIC tm2316414d1_ex99-6img001.jpg GRAPHIC 2648
29 GRAPHIC tm2316414d1_ex99-6img002.jpg GRAPHIC 12318
30 GRAPHIC tm2316414d1_ex99-7img001.jpg GRAPHIC 90387
31 GRAPHIC tm2316414d1_ex99-7img002.jpg GRAPHIC 105716
32 GRAPHIC tm2316414d1_ex99-3img001.jpg GRAPHIC 219329
33 GRAPHIC tm2316414d1_ex99-3img002.jpg GRAPHIC 245401
34 GRAPHIC tm2316414d1_ex99-3img003.jpg GRAPHIC 278283
35 GRAPHIC tm2316414d1_ex99-3img004.jpg GRAPHIC 231811
36 GRAPHIC tm2316414d1_ex99-3img005.jpg GRAPHIC 229778
37 GRAPHIC tm2316414d1_ex99-3img006.jpg GRAPHIC 253158
38 GRAPHIC tm2316414d1_ex99-3img007.jpg GRAPHIC 230005
39 GRAPHIC tm2316414d1_ex99-3img008.jpg GRAPHIC 171630
  Complete submission text file 0001104659-23-063212.txt   14434301
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filed by) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 41 61 551 30 30
VectivBio Holding AG (Subject) CIK: 0001836379 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-92481 | Film No.: 23945376
SIC: 2836 Biological Products, (No Diagnostic Substances)